Actively Recruiting
Study of Lung Immune Cells and Microbiome in Adults with Acute Respiratory Distress Syndrome ARDS
Led by Hvidovre University Hospital · Updated on 2025-03-17
40
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
Researchers are investigating the immune cell populations, activation patterns, cytokine-chemokine environment, and lung microbiome in critically ill intensive care unit patients with acute respiratory distress syndrome ARDS. The study compares these factors between patients with none-to-mild and moderate-to-severe ARDS, focusing on immune cell behavior in the lungs, including T cell activity and microbiome diversity. The study aims to understand how these elements relate to ARDS severity and progression.
CONDITIONS
Brief Title
Pulmonary Immune Cell-microbiome Interactions in ARDS
Research Team
M
MD, PhD, Ronni Plovsing
M
MD Katrine Schneider
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
